Gastrointestinal stromal tumors: Current diagnosis, biologic behavior, and management

Annals of Surgical Oncology

Volumn 7, Issue 9, 2000, Pages 705-712

  Pidhorecky, Ihor ^a   Cheney, Richard T ^a   Kraybill, William G ^a   Gibbs, John F ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

C kit; GIST; Stromal tumor; Surgery

Indexed keywords

CD34 ANTIGEN; STEM CELL FACTOR RECEPTOR;

GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MESENCHYME CELL; PROGNOSIS; REVIEW; STROMA CELL; TUMOR VOLUME;

EID: 0033772093     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0705-6     Document Type: Review

References (52)

1. Primary gastrointestinal sarcomas: Analysis of prognostic variables
2. Smooth muscle tumours of the digestive tract: Report of 160 cases
3. Smooth muscle tumors of the gastrointestinal tract: A 10 year experience
4. Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas
5. Myosarcomas of the stomach: Natural history, prognostic factors and management
6. Smooth muscle tumors of the gastrointestinal tract: Analysis of prognostic factors
7. Smooth muscle tumors of the gastrointestinal tract: A study of 56 cases for a minimum of 10 years
8. Gastrointestinal sarcomas
9. Experimental models for gastric leiomyosarcoma
10. Sarcomas arising after radiotherapy for peptic ulcer disease
11. Sarcomas of the gastrointestinal tract
12. Gastrointestinal stromal tumors
13. The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma
14. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney triad): Natural history, adrenocortical component, and possible familial occurrence
15. Carney's triad: Guidelines for management
16. Gastrointestinal stromal tumors
17. Smooth muscle tumors of the stomach
18. Gastrointestinal stromal tumors
19. Mesenchymal tumors of the gut: Historical perspectives, new approaches, new results, and does it make a difference?
20. Mesenchymal tumors of the gastrointestinal tract: A paradise for acronyms (STUMP, GIST, GANT, and now GIPACT), implications of c-kit in genesis, and yet another of the many emerging roles of the interstitial cell of Cajal in the pathogenesis of gastrointestinal diseases?
21. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors
22. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
23. Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumors
24. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors
25. Sarcomas of the stomach
26. Prognosis of smooth-muscle (stromal) tumors: Dependence on anatomic site
27. Differentiation and risk assessment of gastrointestinal stromal tumors
28. Gastrointestinal stromal tumors: A 'benign' tumor with hepatic metastasis after 11 years
29. Prognostic factors influencing survival in gastrointestinal sarcomas: Implications for surgical management and staging
30. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal tumours
31. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas
32. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors
33. Endosonographic differentiation of benign and malignant stromal cell tumors
34. Fine-needle aspiration of gastrointestinal stromal tumors
35. Comparative study of transrectal ultrasonography, pelvic computerized tomography, and magnetic resonance imaging in preoperative staging of rectal cancer
36. Surgical therapy of esophageal leiomyoma
37. Results of aggressive treatment of gastric sarcoma
38. An institutional review of sarcomas of the large and small intestine
39. Leiomyosarcoma of the esophagus: Results of surgical treatment
40. Surgery for disseminated abdominal sarcoma
41. Leiomyosarcoma of the rectum: Report of a case and review of the literature
42. Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival
43. Laparoscopic resection of submucosal gastric tumors
44. Salvage surgery for patients with recurrent gastrointestinal sarcoma: Prognostic factors to guide patient selection
45. Complete hepatic resection of metastases from leiomyosarcoma prolongs survival
46. Gastrointestinal sarcoma (GIST): A review of surgical management
47. Sarcoma of the stomach: Clinicopathologic study of 43 cases
48. Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: A southwest oncology group study
49. Intraperitoneal chemotherapy in disseminated abdominal sarcoma
50. Intraperitonal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis
51. Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas
52. Sarcoma of the gastrointestinal tract: Separation into favorable and unfavorable prognostic groups by mitotic count